| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55588 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-90 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-11 |
| filingDate |
2016-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-106687592-B |
| titleOfInvention |
Recombinant plasmid, recombinant plasmodium constructed by recombinant plasmid and application of recombinant plasmid |
| abstract |
The invention relates to the field of cell immunotherapy of tumors, in particular to a recombinant plasmid, a recombinant plasmodium constructed by the recombinant plasmid and an application of the recombinant plasmid, wherein the recombinant plasmid is obtained by inserting a liver tumor specific antigen gene into a pL0017 plasmid, and the recombinant plasmodium comprises the recombinant plasmid, compared with plasmid DNA and an RNA vector, the recombinant plasmodium can realize a large amount of in-vivo amplification along with the proliferation of plasmodium, and is favorable for increasing the antigen in vivo. |
| priorityDate |
2016-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |